Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1‐year follow‐up in nine cases

Invasive fusariosis is an infection with Fusarium spp. that primarily affects patients with hematologic malignancies and hematopoietic cell transplant recipients. Wounds, digital ulcers, onychomycosis, and paronychia are the typical cutaneous portals of entry. Early management of mycotic nails in immunocompromised and diabetic hosts is crucial to prevent life‐threatening disease.

[1]  M. Nucci,et al.  Increased Incidence of Invasive Fusariosis with Cutaneous Portal of Entry, Brazil , 2013, Emerging infectious diseases.

[2]  T. Anagnostou,et al.  Fusarium Infection: Report of 26 Cases and Review of 97 Cases From the Literature , 2013 .

[3]  V. Hubka,et al.  [Fusarium as a cause of onychomycosis resistant to common antifungal therapy]. , 2012, Klinicka mikrobiologie a infekcni lekarstvi.

[4]  D. Luo,et al.  A meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole , 2012, The Journal of dermatological treatment.

[5]  R. Ranawaka,et al.  Non-dermatophyte mold onychomycosis in Sri Lanka. , 2012, Dermatology online journal.

[6]  A. Ikram,et al.  Non-dermatophyte moulds as pathogens of onychomycosis. , 2011, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[7]  H. Trau,et al.  A rationale for systemic treatment in onychomycosis with negative results on fungal examination , 2011, Clinical and experimental dermatology.

[8]  A. Andea,et al.  Disseminated Fusarium infection originating from paronychia in a neutropenic patient: a case report and review of the literature. , 2010, Cutis.

[9]  M. Monod,et al.  Onychomycosis Insensitive to Systemic Terbinafine and Azole Treatments Reveals Non-Dermatophyte Moulds as Infectious Agents , 2010, Dermatology.

[10]  C. Lan,et al.  Onychomycosis caused by Fusarium solani in a woman with diabetes , 2009, Clinical and experimental dermatology.

[11]  R. Ranawaka,et al.  Onychomycosis caused by Fusarium sp in Sri Lanka: Prevalence, clinical features and response to itraconazole pulse therapy in six cases , 2008, The Journal of dermatological treatment.

[12]  R. Sharma,et al.  An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis. , 2007, Indian Journal of Dermatology, Venereology and Leprology.

[13]  T. Svidzinski,et al.  Fusarium spp. as agents of onychomycosis in immunocompetent hosts , 2007, International journal of dermatology.

[14]  K. Okuzumi,et al.  Onychomycosis caused by Fusarium proliferatum , 2005, The British journal of dermatology.

[15]  O. Jousson,et al.  Molecular Identification of Fusarium Species in Onychomycoses , 2004, Dermatology.

[16]  R. Ungpakorn,et al.  Prevalence of foot diseases in outpatients attending the Institute of Dermatology, Bangkok, Thailand , 2004, Clinical and experimental dermatology.

[17]  K. Ng,et al.  Onychomycosis in Malaysia , 2004, Mycopathologia.

[18]  K. Goa,et al.  Terbinafine , 2003, American journal of clinical dermatology.

[19]  B. Piraccini,et al.  Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. , 2000, Journal of the American Academy of Dermatology.

[20]  H. Degreef,et al.  Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: a multicenter study with 36 patients. , 1997, Journal of the American Academy of Dermatology.

[21]  A. Ramani,et al.  MOLDS IN ONYCHOMYCOSIS , 1993, International journal of dermatology.

[22]  A. Paller,et al.  Disseminated Fusarium solani Infection With Cutaneous Nodules in a Bone Marrow Transplant Patient , 1988, International journal of dermatology.